Oracle Sets the Date for its First Quarter Fiscal Year 2026 Earnings Announcement

Earnings Results to be released on September 9, 2025, After the Close of the Market Oracle Corporation today announced that its first quarter fiscal year 2026 results will be released on Tuesday, September 9th, after the close of the market. Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to […]

American Public Education, Inc. To Attend Lake Street Capital Markets 9th Annual Best Ideas Growth Conference

American Public Education, Inc. (Nasdaq: APEI), is a leading provider of online and campus-based postsecondary education and career learning to over 125,000 students through three subsidiary institutions, today announced that Angela Selden, Chief Executive Officer, and Gary Janson, SVP Strategy & Growth, will attend the Lake Street Capital Markets 9th Annual Best Ideas Growth Conference

Thornburg Income Builder Opportunities Trust Announces Distribution

Thornburg Income Builder Opportunities Trust (the “Trust”) (NASDAQ: TBLD) today announced a monthly distribution of $0.10417 per share on the Trust's common shares, payable on September 19, 2025, to common shareholders of record as of September 12, 2025. https://mma.prnewswire.com/media/1716788/Thornburg_Logo.jpg The Trust's monthly distribution is shown below: Amount Payable Date Ex-Dividend/Record Date Change from Previous Declaration$0.10417

Mineralys Therapeutics Announces Proposed Public Offering of Common Stock

Mineralys Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire September 02, 2025 RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by

Ascendis to Share Latest Endocrinology Rare Disease Data in 3 Oral Presentations at ASBMR 2025

Ascendis to Share Latest Endocrinology Rare Disease Data in 3 Oral Presentations at ASBMR 2025 GlobeNewswire September 02, 2025 COPENHAGEN, Denmark, Sept. 02, 2025 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced three oral presentations of its latest achondroplasia and hypoparathyroidism data at ASBMR 2025, the annual meeting of the American Society for

HealthEquity Reports Second Quarter Ended July 31, 2025 Financial Results

HealthEquity Reports Second Quarter Ended July 31, 2025 Financial Results GlobeNewswire September 02, 2025 Highlights of the second quarter include: Revenue of $325.8 million, an increase of 9% compared to $299.9 million in Q2 FY25. Net income of $59.9 million, an increase of 67% compared to $35.8 million in Q2 FY25, with non-GAAP net income

Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference

Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference GlobeNewswire September 02, 2025 WESTLAKE VILLAGE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief Financial Officer, will

Cognition Therapeutics Closes $30 Million Registered Direct Offering to Two New Fundamental Institutional Investors, Including a Preeminent Global Investment Firm to Support Phase 3 Development of Zervimesine (CT1812)

(NASDAQ:CGTX), PURCHASE, N.Y., Sept. 02, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, closed its previously announced registered direct offering of 14,700,000 shares of common stock at a purchase price of $2.05 per share. Gross proceeds from the offering were approximately

LAOIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Western Asset Management Company, LLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

(NASDAQ:WATFX),(NASDAQ:WABAX),(NASDAQ:WABCX),(NASDAQ:WAPIX),(NASDAQ:WACSX),(NASDAQ:WABRX),(NASDAQ:WAPAX),(NASDAQ:WAPCX),(NASDAQ:LWCPX),(NASDAQ:WACIX),(NASDAQ:WAPRX),(NASDAQ:WACPX),(NASDAQ:WAPSX), NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Western Asset Management Company, LLC (“WAMCO” or the “Company”), Franklin Resources, Inc. (“Franklin”), and Stephen Kenneth Leech, II (“Leech”) (collectively, “Defendants”). Class Definition This lawsuit

SLQT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SelectQuote, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

(NYSE:SLQT), NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or “the Company”) (NYSE: SLQT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

Scroll to Top